Pharmalot… Pharmalittle… Morning Edition
Make a commentBy Ed Silverman // September 21st, 2007 // 7:11 am
As the week winds down, there is much to follow. In particular, though, we want to thank those of you who write in with ideas, suggestions and tips, many of which have led to interesting items. Please continue to do so. Our door is always open and we value your input. Meanwhile, here are a few tidbits to help your morning along…
Pfizer Talks To Investors About Spinning Off Japan R&D (CNN/Dow Jones)
Exelis And Bristol-Myers Squibb Extend Research Deal (Yahoo/Reuters)
Sepracor To Get Tax Cut For Massachusetts Expansion (Worcester Telegram & Gazette)
CME Czar Goes To Pfizer (Medical Marketing & Media)
AstraZeneca’s Lung-Cancer Drug Lengthened Survival (Bloomberg News)